RFC
COCH icon

Regions Financial Corp’s Envoy Medical COCH Stock Holding History

Regions Financial Corp’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-14,100
Closed -$142K – 831
2023
Q1 		$142K Buy
+14,100
New +$141K ﹤0.01% 800

Other funds holding COCH

AMC
Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return
LIM
Longfellow Investment Management Boston, Massachusetts $480M AUM 8% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Regions Financial Corp's COCH Position: Q2 2023 in Review

Regions Financial Corp sold out of Envoy Medical (COCH) in Q2 2023, closing a stake of 14,100 shares — an estimated $142K sold.

Regions Financial Corp first reported a position in COCH in Q1 2023 and held it in 1 quarter. The position peaked at $142K in Q1 2023. 21 funds tracked by Wall St. Rank hold COCH as of Q2 2023.

  • Regions Financial Corp reported no remaining Envoy Medical position as of Q2 2023 after selling out during the quarter.
  • Regions Financial Corp sold 14,100 Envoy Medical shares in Q2 2023, an estimated $142K.
  • Regions Financial Corp first reported a position in Envoy Medical in Q1 2023 and held it in 1 quarter.
  • Regions Financial Corp's Envoy Medical position peaked at $142K in Q1 2023.
  • 21 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2023.

Based on Regions Financial Corp's 13F filing for Q2 2023, filed 9 Aug 2023.